Yahoo Web Search

Search results

  1. An international nonproprietary name ( INN) is an official generic and nonproprietary name given to a pharmaceutical drug or an active ingredient. [2] INNs are intended to make communication more precise by providing a unique standard name for each active ingredient, to avoid prescribing errors. [1] The INN system has been coordinated by the ...

  2. In 2005, the two-word nomenclature scheme for gene therapy products was formally adopted by the members of the INN Expert Group designated to deal with the selection of nonproprietary names. The 2012 updated scheme is shown in Table 2. Table 2: Two-word scheme for gene therapy products (GTP) (updated in 2012) Prefix.

  3. 4. In devising INN for acids, one-word names are preferred; their salts should be named without modifying the acid name, e.g. “oxacillin” and “oxacillin sodium”, “ibufenac” and “ibufenac sodium”. 5. INN for substances which are used as salts should in general apply to the active base or the active acid.

  4. More than 50 years ago, WHO established the International Nonproprietary Name (INN) Expert Group/WHO Expert Committee on Specifications for Pharmaceutical Preparations, to assign nonproprietary names to medicinal substances, so that each substance would be

  5. People also ask

  6. International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name. General guidance. Mandate.

  7. Feb 4, 2021 · The WHO International Nonproprietary Names Programme would like to highlight that international non-proprietary names (INNs), assigned to well defined pharmaceutical substances, including those used in vaccines, ensure that each substance is recognised globally by a unique and distinct name.

  8. Nonproprietary Names. The inclusion of a name in the lists of Recommended International Nonproprietary Names does not imply any recommendation of the use of the substance in medicine or pharmacy. Lists of Proposed (1–117) and Recommended (1–78) International Nonproprietary Names can be found in Cumulative List No. 17, 2017 (available in CD ...